Deregulation of PTPs can result in both their up- and downregulation, which can explain the discordance between our established association between high expression of PTPRK and poor outcome to AI therapy, while decreased expression of PTPRK has previously been related to poor prognosis in MBC suggesting a more tumor suppressive role [46]. This evidence concerns the gene PTPRK and neoplasm.